Insurers and
Lab Partners


PredictSURE IBD™ is the first validated prognostic test for IBD with measurable economic and health benefits.

How can you help your physicians manage their Crohn’s Disease and ulcerative colitis patients better?

How about a first and only prognostic test?

Towards the right treatment, for the right patient, at the right time 

  • For Crohn’s disease and ulcerative colitis patients 

  • Stratify patients into high and low risk of early and frequent flares 

  • Exploit the window of opportunity at diagnosis to impact on outcomes

  • High risk patients may benefit from early aggressive therapy


1OOO Youngs Road  |  Suite 21O
Buffalo NY 14221 USA
716.431.5757 Fax
Looking for KSL Biomedical? Click HERE.
  • Facebook
  • LinkedIn Social Icon
  • Twitter